Should anticoagulation therapy be withheld in patients with active cancer after 6 months of low-molecular weight heparin?

J Clin Oncol. 2015 May 20;33(15):1713. doi: 10.1200/JCO.2014.60.6384. Epub 2015 Apr 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Male
  • Neoplasms / complications*
  • Venous Thromboembolism / drug therapy*
  • Venous Thrombosis / drug therapy*

Substances

  • Heparin, Low-Molecular-Weight